baber/WOPTO huggingface dataset:
Patent FI-954404-A0 (FI)
Inventor: BAGLEY SCOTT W
IPC: C07D215/36
Filed: 1995-09-18
Abstract: Phenoxyphenylacetic acids and derivatives of the general structural formula I <CHEM> have endothelin antagonist activity and are useful in treating cardiovascular disorders, such as hypertension, postischemic renal failure, vasospasm, cerebral and cardiac ischemia, myocardial infarction, endotoxic shock, benign prostatic hyperplasia, inflammatory diseases including Raynaud's disease and asthma.
Patent FI-955538-A0 (FI)
Inventor: DURSTON DAVID JOHN
IPC: C08L67/02
Filed: 1995-11-16
Abstract: PCT No. PCT/GB94/01042 Sec. 371 Date Nov. 8, 1995 Sec. 102(e) Date Nov. 8, 1995 PCT Filed May 16, 1994 PCT Pub. No. WO94/27298 PCT Pub. Date Nov. 24, 1994Polymer blend for insulating electrical wires comprises a first polymer (polyester) having an inherent L.O.I. not higher than 21% and up to 40% by weight of a polyimide-siloxane (PIS) copolymer. Preferred polyesters are polybutylene terephthalate or polyester-ester block copolymers. Preferred wire constructions have core insulation layer of polyethylene or polyester overlaid with jacket of the polyester/PIS copolymer blend.
Patent FI-962478-A0 (FI)
Inventor: STAMM ANDRE
IPC: A61K9/12
Filed: 1996-06-14
Abstract: A composition for a foam and a process for preparing it are provided, the composition including by weight (a) more than 25% of an active ingredient in powder form; (b) from 1 to 20% of a surfactant; the balance being composed of water, wherein the powder of the active ingredient has a particle size below 20  mu m. Foams, notably for rectal administration, containing this composition with a propellant gas are also provided.
Patent FI-963408-A0 (FI)
Inventor: CAPUDER EGIDIJ
IPC: C07D498/00
Filed: 1996-09-02
Abstract: A process for the isolation of clavulanic acid pharmaceutically acceptable salts thereof, such as potassium clavulanate, from the aqueous fermentation broth of a clavulanic acid-producing microogranism comprises the microfiltration of the broth without prior treatment.
Patent FI-982748-A0 (FI)
Inventor: WALLENIUS JUKKA
IPC: H04L12/14
Filed: 1998-12-18
Abstract: A method and system for charging a subscriber (10) in a telecommunications network comprising nodes (11 and 12) connected to a mediator unit (14), whereby a billing unit (15) comprising the subscriber's (10) charging data can be located outside the network used, preferably in the subscriber's (10) home network, in a subscriber identity module (SIM) or behind an open service architecture (OSA) associated with the network, the method comprising the following steps of: noting in the nodes (11 and 12) the event data related to the services used by the subscriber (10) and reporting the event data to the mediator unit (14), the event data being converted substantially in real time in the mediator unit (14) by applying the network charging algorithms to provide a charging data format understandable to the billing unit (15), expressed preferably as an amount of money spent or as charging pulses, for the updating of the subscriber's (10) charging data between the mediator unit (14) and the billing unit (15).
Patent FI-990003-A0 (FI)
Inventor: SKAR MERETE
IPC: C08F10/02
Filed: 1999-01-04
Abstract: This invention concerns process for producing polyethylene compositions, films prepared thereof and process for the preparation of the films. The process comprises subjecting ethylene, optionally hydrogen and comonomers to polymerization or copolymerization reactions in a multistage polymerization. At least one polymerization stage is conducted essentially in the absence of hydrogen. The polymerization reactions are carried out in the presence of a single-site catalyst capable of forming a composition comprising a low molecular weight component with MFR<HIL><PDAT>2 </SB><PDAT>of at least 10 g/10 min and a density higher than the density of the composition and a high molecular weight component. The melt flow rate of the composition is in the range MFR<HIL><PDAT>2</SB><PDAT>=0.1-5.0 g/10 min and the density of the composition is 915-960 kg/m<HIL><3</SP><PDAT>. The invention makes it possible to produce polyethylene compositions for manufacturing films with a good balance between optical and mechanical properties.</PTEXT>
Patent IL-57795-A0 (IL)
Title: Cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07D501/36
Filed: 1979-07-13
Abstract: There is presented cephalosporin derivatives which are the readily hydrolysable esters and ethers of compounds of the general formula <IMAGE>  (I)  wherein R represents furyl, thienyl or phenyl optionally substituted by halogen, hydroxy, lower alkoxy or lower alkyl, R1 represents lower alkyl or aminocarbonylmethyl and X represents a group of the formula   <IMAGE>  <IMAGE>  <IMAGE>    in which one of the two symbols R2 and R3 represents hydrogen and the other represents lower alkyl and R4 represents lower alkyl, as well as salts of said esters and ethers and hydrates of said esters, ethers and salts.
Patent IL-58288-A0 (IL)
Title: An insrrument for introducing media into the female body
IPC: A61F2/82
Filed: 1979-09-20
Abstract: A dispensing instrument with supported balloon (46) having a dispenser operable to place drug material into the uterine cavity and an expandable balloon (46) cooperating with support structure (59) operable to move the drug material from the uterine cavity into both canals of the Fallopian tubes. The instrument housing carries a piston/cylinder assembly. The balloon (46) is attached to a flexible tubular probe (43) mounted on one housing end. The piston/cylinder assembly is operable to fully collapse the balloon (46). After the balloon (46) is inserted through the cervical opening into the uterine cavity, a drug ampulla is loaded into the instrument. The piston/cylinder assembly is actuated to initially expand the balloon (46) and move a plunger into the ampulla to dispense drug material into the uterine cavity. The balloon (46) is then fully expanded to move the drug material into the canals of the Fallopian tubes. The balloon support structure (59) prevents the balloon (46) from expanding back through the cervical opening into the vaginal passage. The support structure (59) is a monofilament nylon (61, 62, 63, 64) arranged in intersecting latitudinal and longitudinal directions about a lower ballon (46) portion.
Patent IL-70128-A0 (IL)
Title: Polyene compounds,their manufacture and pharmaceutical compositions containing them
IPC: C07F9/54
Filed: 1983-11-03
Abstract: Aromatic retinoids bearing a trifluoromethoxy substituent on the aromatic nucleus which are useful as antitumor agents and in the treatment of dermatological disorders as well as a method for their manufacture are disclosed.
Patent IL-89559-A0 (IL)
Title: Composition and method for repelling birds and animal pests
IPC: A01N25/06
Filed: 1989-03-09
Abstract: The invention provides a sprayable non-aqueous composition for repelling birds and animal pests, comprising a mixture of a tacky polyolefin, a substantially pure silica-based thixotropic agent and an organic solvent or diluent.
Patent IL-90193-A0 (IL)
Title: Polyurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same
IPC: A61K47/48
Filed: 1989-05-04
Abstract: The invention provides a polyurethane amide segmented copolymer selected from:   a) a segmented block polyurethane amide (PEUAm) of the following repeating unit [I] <CHEM> wherein R is hexamethylene, 4,4 min -diphenylmethane, toluene, naphthalene, 4,4 min -dicyclohexylmethane, cyclohexyl, 3,3 min -dimethylphenyl, 3,3 min -dimethyl-diphenylmethane, 4,6 min -xylylene, 3,5,5-trimethylcyclohexyl, 2,2,4-trimethyl-hexamethylene or p-phenylene, R min  is selected from a linear or branched, unsubstituted or substituted hydrocarbyl group. the substituents being selected from halogen or hydroxy, or R min  is a bivalent Si-(R1R2) group, wherein R1 and R2 are identical or different groups selected from hydrogen, alkyl, a double bond-containing hydrocarbyl group, halogen, hydroxy or an aromatic ring-containing group, and  m is a positive integer, A is a bivalent saturated or unsaturated, linear or branched, substituted or unsubstituted hydrocarbyl group, the substituents being selected from halogen, hydroxy, cyano, carboxy or amino groups; or A is an unsubstituted or substituted aromatic ring-containing group, the substituents being selected from halogen, hydroxy, cyano, carboxy or amino groups, and  n is zero or a positive integer; b) a segmented block polyurethane amide of the following repeating unit [II] <CHEM> wherein R is hexamethylene, 4,4 min -diphenylmethane, toluene, naphthalene, 4,4 min -dicyclohexylmethane, cyclohexyl, 3,3 min -dimethylphenyl, 3,3 min -dimethyl-diphenylmethane, 4,6 min -xylylene, 3,5,5-trimethylcyclohexyl, 2,2,4-trimethyl-hexamethylene or p-phenylene, R min  is selected from a linear or branched, unsubstituted or substituted hydrocarbyl group, the substitutents being selected from halogen or hydroxy, or R min  is a bivalent Si-(R1R2) group, wherein R1 and R2 are identical or different groups selected from hydrogen, alkyl, a double bond-containing hydrocarbyl group, halogen, hydroxy or an aromatic ring-containing group, and  m is a positive integer and B and D are each a bivalent, saturated or unsaturated, linear or branched, unsubstituted or substituted hydrocarbyl group, the substituents being selected from halogen, hydroxy, cyano, carboxy or amino groups, or B and D are each an unsubstituted or substituted aromatic ring-containing group, the substituents being selected from halogen, cyano, carboxy or amino groups wherein B and D can be the same or different, and  a and b are identical or different and are each 0 or 1, and X and Y are identical or different grafted substituents, usually bearing biomedical relevance. i
Patent IL-95542-A0 (IL)
Title: Constrained geometry addition polymerization catalysts,processes for their preparation,precursors therefor,method of use and novel polymers formed therewith
IPC: C08F4/659
Filed: 1990-08-30
Abstract: One or more addition polymerizable monomers are polymerized by catalysts comprising a metal monocyclopentadienyl coordination complex and an activating cocatalyst to form novel polymers, including atactic amorphous poly(alpha-olefins), elastic polyethylenes and pseudo-random copolymers.
Patent SE-8803526-A0 (SE)
Title: Sätt att emballera långsträckta föremål samt emballage för genomförande av förfarandet
Inventor: MAGNUSSON HANS
IPC: B65B11/04
Filed: 1988-10-05
Abstract: LAngstrackta foremal, som Nr avsedda att lindas upp pa en trumma (11) med gavlar (13), emballeras genom att en bana (2) bringas att lindas upp pA trumman (11) och till anliggning mot det pA trumman upplindande, lAngstrackta foremalet, Den nAmnda banan (2) uppvisar pA avstand frAn varandra anordnade, styva element (6) med en bredd som är lika med eller understiger avstAndet mellan trummans (11) gavlar (13). r NU' " .„ • * * '0a • • • - a • • 4 4 • :• e • . 5',11771 I: ••11 ••feraAAD ••• • ! 11 :I F. ._ ..:_; I 1 Z Sr:•I ^ I A.'411K-Var- -444w1 —r .ereiY/Jiia_1/5 I I a 81.111111.1.1■IM.1011•1111.0 - 2. I2/.
Patent IL-103510-A0 (IL)
Title: Pharmaceutical compositions containing antibodies for causing immunosuppression
IPC: A61P17/00
Filed: 1992-10-22
Abstract: The present invention relates to the use of preparations of antibodies directed against vCD44 for immunosuppression.
Patent IL-109903-A0 (IL)
Title: Imidazole lipoxygenase inhibitors
IPC: C07D233/54
Filed: 1994-06-06
Abstract: PCT No. PCT/JP94/00836 Sec. 371 Date May 6, 1996 Sec. 102(e) Date May 6, 1996 PCT Filed May 25, 1994 PCT Pub. No. WO94/29299 PCT Pub. Date Dec. 22, 1994Certain novel imidazole derivatives having the ability to inhibit the lipoxygenase enzyme and having formula (I), wherein Y is hydrogen, C1-C8 alkyl, halosubstituted C1-C4 alkyl, phenyl, substituted phenyl, C7-C14 phenylalkyl, C7-C14 (substituted phenyl)alkyl, pyridyl, substituted pyridyl, C6-C13 pyridylalkyl or C6-C13 (substituted pyridyl)alkyl, wherein each substituent is independently halo, nitro, cyano, C1-C4 alkyl, C1-C4 alkoxy, halosubstituted C1-C4 alkyl, halosubstituted C1-C4 alkoxy, NR4R5, CO2R4 or CONR4R5, wherein R4 and R5 are each, independently, hydrogen or C1-C6 alkyl; Ar1 and Ar2 are each, independently, phenylene, mono-substituted phenylene or di-substituted phenylene, wherein the substituents are, independently, halo, C1-C4 alkyl, C1-C4 alkoxy, halo-substituted C1-C4 alkyl or halo-substituted C1-C4 alkoxy; X and X1 are each, independently, O, S, SO or SO2; R' is hydrogen or C1-C4 alkyl; and R2 and R3 are each, independently, methylene, ethylene or propylene. These compounds are useful for the treatment of disease states such as bronchial asthma, skin disorders and arthritis in mammals, and as the active ingredient in pharmaceutical compositions for treating such conditions.
Patent IL-111035-A0 (IL)
Title: Wraparound carton
IPC: B65D71/14
Filed: 1994-09-22
Abstract: PCT No. PCT/US94/10788 Sec. 371 Date Jun. 2, 1995 Sec. 102(e) Date Jun. 2, 1995 PCT Filed Sep. 23, 1994 PCT Pub. No. WO95/08487 PCT Pub. Date Mar. 30, 1995A package comprises a plurality of articles, a strap and a carton of a tubular structure. The articles are arranged in a group of at least one row such that the longitudinal axes of the articles are disposed vertically and parallel to each other. The strap extends generally horizontally around the circumference of the group of articles to hold the articles together in a unit. The carton includes a top wall panel, a pair of side wall panels and a pair of secured base panels. The carton extends around the group of articles such that the side wall panels are disposed over the straight runs of the strap, respectively. At least one of the side wall panels has a restraining flap for limiting vertical displacement of the strap. The flap is hinged to the side edge of the one side wall panel and is folded inwardly of the tubular structure into the space between adjacent articles in the row to be disposed at a location vertically adjoining the adjacent straight run.
Patent IL-138972-A0 (IL)
Title: N,n-disubstituted amides that inhibit the binding of integrins to their receptors
IPC: A61K31/16
Filed: 1999-04-15
Abstract: A method for the inhibition of the binding of  alpha 4 beta 1 integrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compounds that inhibit this binding; pharmaceutically active compositions comprising such compounds; and the use of such compounds either as above, or in formulations for the control or prevention of diseases states in which  alpha 4 beta 1 is involved.
Patent IL-150380-A0 (IL)
Title: Improved hand washing device
IPC: A61L2/08
Filed: 2000-12-22
Abstract: The invention concerns a sanitary device comprising: a cleaning volume (32) defined by walls and open on one side (49); means (38, 43) for detecting the presence of hands in said volume; means (34, 36, 41) for projecting a fluid (39) onto hands present in the cleaning volume.
Patent IL-152374-A0 (IL)
Title: A method of fabricating coded particles
IPC: B01J19/00
Filed: 2001-04-18
Abstract: Coded microparticles for use in chemical or biological library synthesis are produced by delineating particles in a plastics sheet supported on a substrate and removing the particles from the substrate.
Patent IL-161147-A0 (IL)
Title: Antigen arrays presenting il-5, il-3, or eotaxin for treatment of allergic eosinophilic diseases
IPC: C12N7/00
Filed: 2002-11-07
Abstract: The present invention is related to the fields of molecular biology, virology, immunology and medicine. The invention provides a composition comprising an ordered and repetitive antigen or antigenic determinant array, and in particular an array comprising a protein or peptide of IL-5, IL-13 or eotaxin. More specifically, the invention provides a composition comprising a virus-like particle and at least one protein, or peptide of IL-5, IL-13 and/or eotaxin bound thereto. The invention also provides a process for producing the conjugates and the ordered and repetitive arrays, respectively. The compositions of the invention are useful in the production of vaccines for the treatment of allergic diseases with an eosinophilic component and as a pharmaccine to prevent or cure allergic diseases with an eosinophilic component and to efficiently induce immune responses, in particular antibody responses. Furthermore, the compositions of the invention are particularly useful to efficiently induce self-specific immune responses within the indicated context.
Patent IL-173684-A0 (IL)
Title: Disodium-4,4'-azo-bis-salicylate and pharmaceutical compositions containing the same
IPC: A61P1/06
Filed: 2006-02-13
Abstract: Methods and formulations for treating inflammatory bowel disease are disclosed. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of 4-aminosalicylic acid and/or 5-aminosalicylic acid to affected areas of the intestine. The methods and formulations comprise modified-release elements, providing for drug delivery to the affected or desired area. Diseases and conditions treatable with the present invention include Crohn's disease and ulcerative colitis.
Patent IL-180743-A0 (IL)
Title: Variable rate broadcast with soft handoff
IPC: H04W36/18
Filed: 2007-01-16
Abstract: A method of variable rate broadcasting with soft handoff is disclosed, the method comprising determining a number m of transmission slots allocated for broadcast transmissions, each transmission slot having a slot index value; selecting a transmission slot; and upon determining that the slot index value associated with the selected transmission slot is less than or equal to the number m of transmission slots allocated for broadcast transmissions, identifying one or more broadcast packets received from a plurality of access points in the selected transmission slot, and soft combining the received broadcast packets.
Patent RO-127003-A0 (RO)
Title: Interactive game
Inventor: SVEC MARIAN
IPC: A63F3/08
Filed: 2011-04-06
Abstract: The invention relates to an interactive game, in particular, to a game permitting the interested persons to bet on the winner of a competition, even when they are far from the place of the event. According to the invention, the game consists in that an organizer transmits, via a TV channel and/or the Internet and/or some local monitors, the participants in the competition, the quotas thereof and a counter indicating the time left to the competition start, and the gamblers intending to participate, i.e. to bet on one or several competitors have to make an account on an organizer's server, account to be loaded by the gambler with an amount of money equal to at least the value of the minimal stake for a bet, the account being loaded, preferably, through a classic telephone line or through an overcharged mobile telephone connection made available by the organizer, where, by means of said telephone line connected to the server on which the gambler account is registered, the gambler indicates at least one competitor/some competitors he bets on and the selected type of bet, while the server blocks the access to the telephone line during the competition and indicates this fact on the TV screens/monitors, and then, at the end of the competition, the server operating the increase or reduction of the value in the gambler's account, as the case may be, according to the conditions set out by the game rules, and in case the gambler wins, the server will let him know the value of the prize.
Patent RO-132459-A0 (RO)
Title: Biocidal rac () substance and process for preparing the same
Inventor: SIMEDREA FLORIN
IPC: A61L2/18
Filed: 2017-11-14
Abstract: The invention relates to a biocidal substance of type 1 or 2, to be used for human hygiene and for disinfecting private or public spaces, to an installation and to a process for preparing the same. According to the invention, the biocidal substance comprises water with a pH ranging between 0 and 7 and colloidal Ag in concentration of 1...150 ppm, depending on its purpose. The claimed installation comprises a water ionising apparatus (1) provided with electrodes (6 and 7) supplied with a current of 220 W from the rectifier (8), the positive electrode being introduced into a tank (4) of a volume V, and the negative one into a tank (5) of a volume V, by means of which the tap water (3) is separated into acid and alkaline water, respectively, an electrolyser (2) provided with two electrodes (12 and 13) of pure Ag, connected to the direct current source (14) of 9...12 V, two electronic pH-meters (9 and 10) whose sensors are mounted within the tanks (4 and 5) of the ionizing apparatus (1), controlling the pH values in the two tanks, and a semipermeable square-shaped separation membrane (11), which separates the two volumes, made of polyethylene having a porosity of 60%, at the most, an average diameter of pores of 0.1 μm and an electric resistance of 0.7 mΩ/dm, such that it allows the pH to be maintained constant in both tanks (4 and 5), due to the pore distribution. The claimed process consists in separating the tap water into acid water in a tank (4) and alkaline water in another tank (5), respectively, by means of the ionizing apparatus (1), while controlling the pH values within the preset limits, followed by introducing the colloidal silver by means of the electrolyser (2) provided with electrodes (12 and 13) of pure Ag, such that the time of connection to the direct current source (14) is established depending on the necessary amount of Ag, said Ag being passed in water in colloidal form, which does not loose its properties, and the membrane (11) maintaining constant the pH value within the tanks (4 and 5).
Patent RO-134058-A0 (RO)
Title: Microstructured substrate for surface plasmon resonance () spectroscopy measurements and process for manufacturing the same
Inventor: EVANGHELIDIS ALEXANDRU IONUŢ
IPC: G01N21/55
Filed: 2019-11-27
Abstract: The invention relates to a microstructured substrate which can be used to perform surface plasmon resonance measurements, having applications in the field of biosensors, and to a process for manufacturing the same. The claimed substrate is made up of a glass substrate, an optically transparent metallic film, a rarefied network of polymeric fibres, and an additional optically transparent metallic film. The claimed process consists in applying an oxygen plasma cleaning/activation treatment onto a glass plate, coating it with an optically transparent metallic thin film, applying a second oxygen plasma cleaning/activating treatment onto the metal-coated plate, deposition, on the metal-coated plate, of a rarefied network of polymeric fibres by electro-spinning, application of a new oxygen plasma cleaning/activation treatment of the metal-coated and fiber-coated plate, and deposition of an additional metallic thin film, the successive plasma treatments and the deposition of the polymeric fibre network improving the adhesion of the metal layer, the mechanical strength and the operating life of the whole assembly, while the electrospun fibres can improve the plasmon response.
Patent MC-2081-A1 (MC)
Inventor: GARY LEE OLSON
IPC: A61K31/4015
Filed: 1990-01-16
Abstract: [(5-Oxo-2-pyrrolidinyl)methyl]cyclohexaneacetamides of the formula   <CHEM> wherein R1 is hydrogen, lower alkyl or aryl-lower alkyl; R2 is hydrogen, lower alkyl, aryl, aryl-lower alkyl, <CHEM> wherein R5 and R6 are hydrogen, lower alkyl or aryl-lower alkyl; R3 and R4, independently, are hydrogen, lower alkyl or aryl-lower alkyl;  and enantiomers, diastereomers, and racemates thereof, and, when R2 <CHEM> pharmaceutically acceptable acid addition salts thereof exhibit cognitive enhancement and antiamnestic activity and are therefore useful, for example, in treating memory deficits associated with Alzheimer's disease or age-associated memory impairment.